{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:10:29Z","timestamp":1760235029862,"version":"build-2065373602"},"reference-count":31,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Symmetry"],"abstract":"<jats:p>Type-1 diabetes mellitus is a chronic disease that is constantly monitored worldwide by researchers who are strongly determined to establish mathematical and experimental strategies that lead to a breakthrough toward an immunological treatment or a mathematical model that would update the UVA\/Padova algorithm. In this work, we aim at a nonlinear mathematical analysis related to a fifth-order ordinary differential equations model that describes the asymmetric relation between C-peptides, pancreatic cells, and the immunological response. The latter is based on both the Localization of Compact Invariant Set (LCIS) appliance and Lyapunov\u2019s stability theory to discuss the viability of implementing a possible treatment that stabilizes a specific set of cell populations. Our main result is to establish conditions for the existence of a localizing compact invariant domain that contains all the dynamics of diabetes mellitus. These conditions become essential for the localizing domain and stabilize the cell populations within desired levels, i.e., a state where a patient with diabetes could consider a healthy stage. Moreover, these domains demonstrate the cell populations\u2019 asymmetric behavior since both the dynamics and the localizing domain of each cell population are defined into the positive orthant. Furthermore, closed-loop analysis is discussed by proposing two regulatory inputs opening the possibility of nonlinear control. Additionally, numerical simulations show that all trajectories converge inside the positive domain once given an initial condition. Finally, there is a discussion about the biological implications derived from the analytical results.<\/jats:p>","DOI":"10.3390\/sym13071238","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T10:50:38Z","timestamp":1625827838000},"page":"1238","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nonlinear Analysis of the C-Peptide Variable Related to Type 1-Diabetes Mellitus"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9839-4711","authenticated-orcid":false,"given":"Diana","family":"Gamboa","sequence":"first","affiliation":[{"name":"Posgrado en Ciencias de la Ingenier\u00eda, Tecnol\u00f3gico Nacional de M\u00e9xico\/I.T. Tijuana, Blvd. Alberto Lim\u00f3n Padilla s\/n, Mesa de Otay, Tijuana 22454, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"V\u00e1zquez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Posgrado en Ciencias de la Ingenier\u00eda, Tecnol\u00f3gico Nacional de M\u00e9xico\/I.T. Tijuana, Blvd. Alberto Lim\u00f3n Padilla s\/n, Mesa de Otay, Tijuana 22454, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Posgrado en Ciencias de la Ingenier\u00eda, Tecnol\u00f3gico Nacional de M\u00e9xico\/I.T. Tijuana, Blvd. Alberto Lim\u00f3n Padilla s\/n, Mesa de Otay, Tijuana 22454, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-8442","authenticated-orcid":false,"given":"Paul J.","family":"Campos","sequence":"additional","affiliation":[{"name":"Posgrado en Ciencias de la Ingenier\u00eda, Tecnol\u00f3gico Nacional de M\u00e9xico\/I.T. Tijuana, Blvd. Alberto Lim\u00f3n Padilla s\/n, Mesa de Otay, Tijuana 22454, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_2","unstructured":"World Health Organization (2019). Global Action Plan on Physical Activity 2018\u20132030: More Active People for a Healthier World, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"108362","DOI":"10.1016\/j.diabres.2020.108362","article-title":"Beyond 2020: Modelling obesity and diabetes prevalence","volume":"167","author":"Ampofo","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12963-018-0166-4","article-title":"Projection of the future diabetes burden in the United States through 2060","volume":"16","author":"Lin","year":"2018","journal-title":"Popul. Health Metrics"},{"key":"ref_9","first-page":"110","article-title":"Minimal modeling, partition analysis, and the estimation of insulin sensitivity","volume":"39","author":"Bergman","year":"1980","journal-title":"Fed. Proc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"E667","DOI":"10.1152\/ajpendo.1979.236.6.E667","article-title":"Quantitative estimation of insulin sensitivity","volume":"236","author":"Bergman","year":"1979","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/1932296818785642","article-title":"Modeling of diabetes and its clinical impact","volume":"12","author":"Fritzen","year":"2018","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0954411917702931","article-title":"In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies","volume":"231","author":"Viceconti","year":"2017","journal-title":"Proc. Inst. Mech. Eng. Part H J. Eng. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Aluru, S. (2005). Handbook of Computational Molecular Biology, CRC Press.","DOI":"10.1201\/9781420036275"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Castillo-Chavez, C., Blower, S., Van den Driessche, P., Kirschner, D., and Yakubu, A.A. (2002). Mathematical Approaches for Emerging and Reemerging Infectious Diseases: An Introduction, Springer Science & Business Media.","DOI":"10.1007\/978-1-4757-3667-0"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1137\/090757009","article-title":"On identifiability of nonlinear ODE models and applications in viral dynamics","volume":"53","author":"Miao","year":"2011","journal-title":"SIAM Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00125-006-0559-y","article-title":"C-peptide is a bioactive peptide","volume":"50","author":"Wahren","year":"2007","journal-title":"Diabetologia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2337\/dc16-0360","article-title":"Fall in C-peptide during first 4 years from diagnosis of type 1 diabetes: Variable relation to age, HbA1c, and insulin dose","volume":"39","author":"Hao","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc18-0465","article-title":"C-peptide decline in type 1 diabetes has two phases: An initial exponential fall and a subsequent stable phase","volume":"41","author":"Shields","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1007\/s11538-019-00636-7","article-title":"Tumor Clearance Analysis on a Cancer Chemo-Immunotherapy Mathematical Model","volume":"81","author":"Valle","year":"2019","journal-title":"Bull. Math. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2050150","DOI":"10.1142\/S0218127420501503","article-title":"A Cancer Model for the Angiogenic Switch and Immunotherapy: Tumor Eradication in Analysis of Ultimate Dynamics","volume":"30","author":"Starkov","year":"2020","journal-title":"Int. J. Bifurc. Chaos"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Valle, P.A., Coria, L.N., and Plata, C. (2021). Personalized Immunotherapy Treatment Strategies for a Dynamical System of Chronic Myelogenous Leukemia. Cancers, 13.","DOI":"10.3390\/cancers13092030"},{"key":"ref_22","first-page":"4","article-title":"Hardware Implementation of a Non-Linear Observer for a Diabetes Mellitus Type 1 Mathematical Model","volume":"23","author":"Gamboa","year":"2019","journal-title":"Comput. Sist."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gamboa, D., V\u00e1zquez, C.E., and Campos, P.J. (2020). Nonlinear Analysis for a Type-1 Diabetes Model with Focus on T-Cells and Pancreatic \u03b2-Cells Behavior. Math. Comput. Appl., 25.","DOI":"10.3390\/mca25020023"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1137\/060661144","article-title":"Modeling cyclic waves of circulating T cells in autoimmune diabetes","volume":"67","author":"Mahaffy","year":"2007","journal-title":"SIAM J. Appl. Math."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.physleta.2005.12.104","article-title":"Localization of compact invariant sets of the Lorenz system","volume":"353","author":"Krishchenko","year":"2006","journal-title":"Phys. Lett. A"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s10625-006-0003-6","article-title":"Localization of invariant compact sets of dynamical systems","volume":"41","author":"Krishchenko","year":"2005","journal-title":"Differ. Equations"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00202-016-0491-1","article-title":"Nonlinear speed sensorless control of a surface-mounted PMSM based on a Thau observer","volume":"100","author":"Campos","year":"2018","journal-title":"Electr. Eng."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","article-title":"A practical review of C-peptide testing in diabetes","volume":"8","author":"Leighton","year":"2017","journal-title":"Diabetes Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00125-018-4791-z","article-title":"What do we know about the trends in incidence of childhood-onset type 1 diabetes?","volume":"62","author":"Lawrence","year":"2019","journal-title":"Diabetologia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12933-019-0935-9","article-title":"Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases","volume":"18","author":"Hang","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.cmet.2019.01.021","article-title":"Targeted elimination of senescent beta cells prevents type 1 diabetes","volume":"29","author":"Thompson","year":"2019","journal-title":"Cell Metab."}],"container-title":["Symmetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-8994\/13\/7\/1238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:28:25Z","timestamp":1760164105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-8994\/13\/7\/1238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["sym13071238"],"URL":"https:\/\/doi.org\/10.3390\/sym13071238","relation":{},"ISSN":["2073-8994"],"issn-type":[{"type":"electronic","value":"2073-8994"}],"subject":[],"published":{"date-parts":[[2021,7,9]]}}}